03
2018-05
BrosMed Medical Announces Completes Successful FDA Inspection
Brosmed, Dongguan., April 28, 2018–Brosmed Medical Co. ,Ltd, a leading provider of medical device of cardiovascular and endovascular since 2012, is pleased to announce it successfully completed 4 days Quality System/Current Good Manufacturing Practice regulations for medical devices (21 CFR Part 820) inspection from FDA. This comes as a result of Brosmed medical 5 years ongoing commitment to the highest levels of quality standards.
2018-05-03
11
2018-01
BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA
BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA.
2018-01-11
30
2017-08
BrosMed Medical Announces Japanese Approval and Launch of Artimes™ and Apollo™ PTCA In Japan Market
BrosMed Medical Announces Japanese Approval and Launch of Artimes™ and Apollo™ PTCA In Japan Market.
2017-08-30
02
2017-04
BrosMed Announces Strategic Agreement with Cardinal Health
BrosMed Announces Strategic Agreement with Cardinal Health.
2017-04-02
14
2016-12
BrosMed Announces FDA 510(k) Clearance and Launch of Hermes™ NC 0.035 OTW PTA, Achilles™ NC 0.018 OTW PTA and Castor™ NC 0.014 OTW PTA Balloon Dilatation Catheters.
2016-12-14
08
2016-08
BrosMed Announces FDA 510(k) Clearance and Launch of Additional Configurations of Apollo™ NC PTCA Balloon Catheters in the United States and North America Market
2016-08-08
13
2016-03
BrosMed Announces CE Mark and Launch of Conger™ Hydrophilic Coated Wire
BrosMed Announces CE Mark and Launch of Conger™ Hydrophilic Coated Wire
2016-03-13
01
2015-08
BrosMed Enters the USA Coronary Angioplasty Catheter Market
BrosMed Enters the USA Coronary Angioplasty Catheter Market August 1st, 2015—BrosMed announced that BrosMed Medical and US Endovascular entered into an exclusive agreement to distribute coronary angioplasty catheters in the USA market.
2015-08-01